• Main
  • Molecular Analysis of Cancer Immunoresistance

    Prof. Zvi Fishelson, Ph.D.
    Department of Cell and Developmental Biology

    The long-term goal of our research is to develop a novel treatment for immune resistant cancers. Our research includes characterization of the mechanism of complement dependent cytotoxicity and of the basis for elevated resistance of cancer cells to cell death, and design of novel reagents that sensitize cancer cells to cell death. Research methods used include analyses of cell growth and death and mitochondrial activity, western blotting, enzyme-linked immunosorbent assay (ELISA), immunoprecipitation, confocal fluorescence microscopy, Fluorescence-activated Cell Sorting (FACS), peptide analysis by mass spectrometry, electon microscopy, and analysis of cancer growth in animal models.

     

    Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
    UI/UX Basch_Interactive